-+ 0.00%
-+ 0.00%
-+ 0.00%

D. Boral Capital Maintains Buy on Anavex Life Sciences, Maintains $24 Price Target

Benzinga·12/15/2025 13:02:18
语音播报
D. Boral Capital analyst Jason Kolbert maintains Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $24 price target.